U.S., Aug. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07755813) titled 'Pirfenidone as Treatment of Chronic Pancreatitis' on Aug. 04.
Brief Summary: The proposed project is focused towards evaluation of Pirfenidone as a novel therapeutic strategy in patients with chronic pancreatitis (CP).
Study Start Date: Aug., 2026
Study Type: INTERVENTIONAL
Condition:
Chronic Pancreatitis
Intervention:
DRUG: Pirfenidone 267 mg Oral Tablet
Oral tablets taken with food three times daily. Titrated over 14 days: one tablet three times daily in week 1, two tablets three times daily in week 2, and three tablets three times daily (801 mg three times daily) from week 3 onward. Continued for 48 weeks unless reduced or...